Status: Not yet recruiting
Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL
To evaluate the efficacy and safety of pirtobrutinib combined with R-CHOP in patients with newly diagnosed non-GCB diffuse large B-cell lymphoma (DLBCL)
Participants needed: 34
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Changzhou No.2 People's HospitalUpdated: Aug 6, 2026Locations: 1
Eligibility criteria
Histopathologically confirmed non-GCB diffuse large B-cell lymphoma (DLBCL) (per... [+7]
Central nervous system involvement; [+13]